HearingTracker
Industry news · Business & finance← The news desk

✦ The Dispatch

Will the Amplifon-GN Deal Redraw the U.S. Hearing Aid Map?

A dispatch from Hearing Tracker — filed

Brand logos grid featuring Amplifon, Miracle-Ear, Audigy, ReSound GN, GAES médica, Beltone, and Jabra GN on white background
✦ PlateBrand logos grid featuring Amplifon, Miracle-Ear, Audigy, ReSound GN, GAES médica, Beltone, and Jabra GN on white background

Continue reading at Hearing Tracker

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change for individual clinical practice yet — but independent clinic owners and dispensers should monitor deal progress, as vertical integration could affect product access and pricing terms.

✦ Why It Matters ✦

Vertical integration of a dominant retail chain with a top-five manufacturer could constrain independent audiologists' access to ReSound/Jabra products and shift competitive power in the U.S. market.

✦ Key Points ✦
  1. 01Analysis explores how the Amplifon–GN deal could restructure the U.S. hearing aid competitive landscape.
  2. 02GN's retail brands (Beltone, Miracle-Ear) and manufacturing brands (ReSound, Jabra) give Amplifon cross-market reach.
  3. 03Independent hearing care providers may face reduced access or less favorable terms for GN products post-merger.
  4. 04Regulatory scrutiny (antitrust review) is a key variable in whether and how the deal closes.
  5. 05The deal could accelerate vertical integration trends already underway in the industry.
✦ Claims & Evidence ✦

The Amplifon–GN acquisition could reshape the competitive landscape of the U.S. hearing aid market.

opinionpartially supported
✦ Related stories ✦